State Key Laboratory of Oncology in Southern China, Cancer Center of Sun Yat-Sen University, Guangzhou, China.
J Transl Med. 2009 Dec 22;7:110. doi: 10.1186/1479-5876-7-110.
Tumor Protein p53 (p53), cyclin-dependent kinase inhibitor 1A (p21/WAF1), and murine double minute 2 (MDM2) participate in the regulation of cell growth. Altered expression of these gene products has been found in malignant tumors and has been associated with poor prognosis. Our aim was to investigate the expression of the 3 proteins in hepatocellular carcinoma (HCC) and their prognostic significance.
We examined p53, p21/WAF1, and MDM2 expression in 181 pairs of HCC tissues and the adjacent hepatic tissues by performing immunohistochemistry and examined the expression of the 3 proteins in 7 pairs of HCC tissues and the adjacent hepatic tissues by using western blot analysis.
The expression of p53, p21/WAF1, and MDM2 in the HCC tissues was significantly higher than those in the adjacent hepatic tissues (P < 0.05). A statistical correlation was observed between p53 and p21/WAF1 expression in HCC tissues (R = 0.195, P = 0.008). A statistical correlation was observed between expression of p53 and p21/WAF1 (R = 0.380, P = 0.000), p53 and MDM2 (R = 0.299, P = 0.000), p21/WAF1 and MDM2 (R = 0.285, P = 0.000) in 181 liver tissues adjacent to the tumor. Patients with a low pathologic grade HCC (I+II) had a higher tendency to express p53 on tumor cells than the patients with high pathologic grade HCC (III+IV) (P = 0.007). Survival analysis showed that positive p21/WAF1 expression or/and negative MDM2 expression in HCC was a predictor of better survival of patients after tumor resection (P < 0.05).
The proteins p53, p21/WAF1, and MDM2 were overexpressed in all the HCC cases in this study, and p53 and p21/WAF1 overexpression were positively correlated. The expression of p21/WAF1 and MDM2 can be considered as 2 useful indicators for predicting the prognosis of HCC.
肿瘤蛋白 p53(p53)、细胞周期蛋白依赖性激酶抑制剂 1A(p21/WAF1)和鼠双微体 2(MDM2)参与细胞生长的调节。这些基因产物的表达改变已在恶性肿瘤中发现,并与预后不良相关。我们的目的是研究肝癌(HCC)中这 3 种蛋白的表达及其预后意义。
我们通过免疫组织化学法检测了 181 对 HCC 组织及其相邻肝组织中 p53、p21/WAF1 和 MDM2 的表达,并通过 Western blot 分析检测了 7 对 HCC 组织及其相邻肝组织中这 3 种蛋白的表达。
HCC 组织中 p53、p21/WAF1 和 MDM2 的表达明显高于相邻肝组织(P<0.05)。在 HCC 组织中观察到 p53 和 p21/WAF1 的表达之间存在统计学相关性(R=0.195,P=0.008)。在 181 对肿瘤旁肝组织中观察到 p53 和 p21/WAF1 的表达(R=0.380,P=0.000)、p53 和 MDM2 的表达(R=0.299,P=0.000)、p21/WAF1 和 MDM2 的表达(R=0.285,P=0.000)之间存在统计学相关性。低病理分级 HCC(I+II)患者的肿瘤细胞中 p53 的表达倾向高于高病理分级 HCC(III+IV)患者(P=0.007)。生存分析显示,HCC 中 p21/WAF1 表达阳性和/或 MDM2 表达阴性是肿瘤切除后患者生存的预测因子(P<0.05)。
在本研究中,所有 HCC 病例均过度表达了蛋白 p53、p21/WAF1 和 MDM2,且 p53 和 p21/WAF1 的过度表达呈正相关。p21/WAF1 和 MDM2 的表达可以作为预测 HCC 预后的 2 个有用指标。